T and NK cell abundance defines two distinct subgroups of renal cell carcinoma-Reference-Cited by-同舟云学术

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

Published:2022-01-04 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lee Moon Hee¹²^ORCID,Järvinen Petrus³^ORCID,Nísen Harry³,Brück Oscar¹²,Ilander Mette¹²,Uski Ilona¹²,Theodoropoulos Jason¹²,Kankainen Matti¹²⁴^ORCID,Mirtti Tuomas⁵^ORCID,Mustjoki Satu¹²⁴^ORCID,Kreutzman Anna¹²^ORCID

Affiliation:

1. Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

2. Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

3. Abdominal Center, Urology, Helsinki University and Helsinki University Hospital, Helsinki, Finland

4. iCAN Digital Precision Cancer Medicine Flagship, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

5. Department of Pathology, Helsinki University Hospital and Research Program in Systems Oncology, University of Helsinki, Finland

Funder

Academy of Finland

Sigrid Jusélius Foundation

Medicinska Understödsföreningen Liv och Hälsa

K Albin Johansson Foundation

Päivikki and Sakari Sohlberg Foundation

Signe and Ane Gyllenberg Foundation

Helsinki Institute of Life Sciences

State funding for university-level health research in Finland

Relander Foundation

Doctoral Program in Clinical Research

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1993042

Reference47 articles.

1. Renal cell carcinoma

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics

4. The genetic basis of kidney cancer: a metabolic disease

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

2. The two types of immune microenvironment of renal cancer;Russian Journal of Biotherapy;2024-06-26

3. Amplifying cancer chemoimmunotherapy through F4/80+CD11c+ DC-like macrophages induced by micellar docetaxel together with a TLR7/8 nanoagonist;Nano Today;2024-02

4. Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma;Frontiers in Oncology;2023-10-26

5. Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis;Translational Cancer Research;2023-10